This piece of commissioned research discusses how health care expenditure produces health...
Case Studies
A Briefing Paper on Health Care and Pharmaceutical Expenditure
Advance Purchase Contracts Scoping Study
Preparation of a briefing paper about advance purchase contracts for vaccines, drugs and diagnosis...
Alzheimer's treatments
On behalf of a group of pharmaceutical companies, OHE reviewed the non-clinical evidence...
American Pharmaceutical Group 'Headroom for Innovation in Primary Care'
OHE Consulting undertook this project for the American Pharmaceutical Group to investigate...
Assessing the Impact of -Payment by Results-
Collaborating with the University of Aberdeen Health Economics Research Unit to evaluate...
Case Studies in Personalized Medicine: Value, Incentives and Implications
The objective of these case studies would be to improve understanding of how these complex...
Cost and Performance Indicator Information for Long-Term Condition Benefits Assessment
For a telecoms company we provided NHS cost and performance indicator information...
Donor Investment Choices: Modeling the value for money of investing in PD-PPPs as compared to other health care and non-health care interventions
An analysis of whether the expected public health and broader economic return from a PD-PPP...
Economic Analysis of the NHS Market for Healthcare Related Products
OHE Consulting was commissioned by the Association of British Healthcare Industries (ABHI) to undertake a preliminary economic analysis of the NHS market for healthcare related products.
EFPIA Incremental Innovation
Characterising “innovation” in a way that maximizes and protects the potential value of the...
EUCAN Task Force
Work for an EU CAN Task Force re draft of “A Policy Took Kit on Therapeutic Equivalence (TE)...
European HTA
OHE Consulting prepared a draft internal position paper to help an international pharmaceutical company develop...
Evidence Based Medicine
A review of the methods used by a sample of organizations to develop guidelines/clinical decision...
Global Health: Rockefeller/Gates Projects
Approximately 60% of deaths and disability adjusted life years (DALYs) lost in low-income countries are attributable to communicable diseases, such as HIV-AIDS, tuberculosis and malaria. Deployment of existing technologies to prevent or treat
Health Care - The Potential Access and Efficiency Benefits of Mobile Communications
This article for Vodafone outlines the drivers behind the upward trend in costs in Western European Health care systems, the measures .....
Health Technology Assessment Toolkit
OHE Consulting was commissioned by the European Federation of Pharmaceutical Industries...
HTA Boards
OHE Consulting was commissioned by a major pharmaceutical company to identify key experts who have been involved in economic...
IPPPH - Forecasting the Medium Term Resource Requirements of the Product Development PPPs
OHE conducted a study of the medium term resource requirements of product development...
Medical Savings Accounts
Medical savings accounts (MSAs) are the voluntary or compulsory contributions of payments...
NICE Data Sets
OHE Consulting, in conjunction with City University and Abacus International, was commissioned...
Orphan Drugs, Oxford University
Analysing the expected costs and benefits of a TB vaccine being developed by the...
Other Major Projects
Assisting a top ten pharmaceutical company with scenario planning around the impact of existing ...
Predicting the Competitive Evolution of Biosimilars
Biologics or biopharmaceutical agents are medicines that originate from biotechnology processes. Examples of such agents include hormones e.g. insulin, growth hormone, other biological proteins e.g. erythropoietin (EPO) and monoclonal antibodies ...
Pricing and Reimbursement
OHE Consulting advises major multinational pharmaceutical companies on trends in pricing...
Sanofi-Synthelabo - Cost-Effectiveness Thresholds
Clive Pritchard presented Sanofi-Synthelabo a review of what is known about how extensively...
The Many Faces of Innovation
This article summarises major points from a study by OHE Consulting for the European Federation...
The UK Health Select Committee - Investigating Department of Health and National Health Service expenditure
Jon Sussex and Peter Yuen provided specialist advice to the House of Commons Health...
The Value of Patient Information
This project is designed to collect, organise and assess quantitative evidence about the...
The World Bank - Capital Financing And Capital Charging In Health Care Systems
Jon Sussex has produced a Working Paper and book chapter for the World Bank...
Transferable Intellectual Property Rights
A study funded by four pharmaceutical companies as part of an industry/European...
UK Department of Health
For the Department of Health, the OHE examined the business case for rolling-out clinical...
UK Dept Of Health - The Business Case For A Roll-Out Of Clinical Research Centres To Strengthen NHS Research
On behalf of the Department of Health, the OHE examined the business case for rolling-out clinical...
Value of the BPG to the UK Economy
The aim of this project was to estimate the value of the British Pharmaceutical Group (BPG)...
VFA, Germany - Institute for Quality and Economic Efficiency in the Health Care Sector (IQWiG)
For the VFA, Germany, OHE prepared a response to a paper recently issued by the new...
What Third Party Payers Want
Assisting a global pharmaceutical company with management of their R&D portfolio we analysed...
WHO CIPIH - Intellectual Property and Neglected Diseases
An exploration of incentives to encourage, Private Sector R&D into global health...